2005
DOI: 10.1021/jm050920y
|View full text |Cite
|
Sign up to set email alerts
|

Targeting FtsZ for Antituberculosis Drug Discovery:  Noncytotoxic Taxanes as Novel Antituberculosis Agents

Abstract: Screening of 120 taxanes identified a number of compounds that exhibited significant antituberculosis activity. Rational optimization of selected compounds led to the discovery that the C-seco-taxane-multidrug-resistance (MDR) reversal agents (C-seco-TRAs) are noncytotoxic at the upper limit of solubility and detection (>80 microM), while maintaining MIC(99) values of 1.25-2.5 microM against drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis (MTB). Treatment of MTB cells with TRA 3aa and 1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
89
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 102 publications
(95 citation statements)
references
References 11 publications
4
89
0
Order By: Relevance
“…Nevertheless, as we demonstrated in this work, concentrations within the soluble range of these drugs inhibited the growth of M. tuberculosis. It is well established in other organisms and in M. tuberculosis that inhibition of FtsZ leads to smooth filamentous cells while, in contrast, inhibition of FtsI produces filamentous cells with distinct septi Huang et al, 2006;Pogliano et al, 1997;Romberg & Levin, 2003). Analysis of M. tuberculosis treated with the benzimidazole compounds (FtsZ inhibitors) or known FtsI inhibitors (cephalexin and piperacillin) revealed cellular morphologies fully consistent with observations in other bacteria (Romberg & Levin, 2003).…”
Section: Discussionsupporting
confidence: 73%
See 2 more Smart Citations
“…Nevertheless, as we demonstrated in this work, concentrations within the soluble range of these drugs inhibited the growth of M. tuberculosis. It is well established in other organisms and in M. tuberculosis that inhibition of FtsZ leads to smooth filamentous cells while, in contrast, inhibition of FtsI produces filamentous cells with distinct septi Huang et al, 2006;Pogliano et al, 1997;Romberg & Levin, 2003). Analysis of M. tuberculosis treated with the benzimidazole compounds (FtsZ inhibitors) or known FtsI inhibitors (cephalexin and piperacillin) revealed cellular morphologies fully consistent with observations in other bacteria (Romberg & Levin, 2003).…”
Section: Discussionsupporting
confidence: 73%
“…3A-D) and this was consistent with the inhibition of Z-ring formation Huang et al, 2006). As a control, M. tuberculosis cultures were also treated with 20 mM cephalexin and 40 mM piperacillin, two known inhibitors of FtsI (Pogliano et al, 1997).…”
Section: Effect Of Ftsz Inhibition On Bacterial Viability and Cell Mosupporting
confidence: 76%
See 1 more Smart Citation
“…As a continued study, Ojima et al disclosed that the conjugated ester group when it is coupled with a ring-opened core (TRA 10a (42 in Figure 7) or 10b (43 in Figure 7)) can enhance the potency of taxanederived small molecule targeting at M. tuberculosis FtsZ. Moreover, these compounds are clearly much less cytotoxic than paclitaxel (200-1,000 times less toxic) and 40 against mammalian cells [115].…”
Section: Taxane Derivativesmentioning
confidence: 99%
“…28,29 The in vitro activities of the ultimate products were evaluated using enzyme inhibition and whole cell antibacterial assays as described previously (Table 1-Table 3). 22,33,34 In general, addition of a bulky substituent at either the ortho, meta or para position of the B ring of 19 or incorporation of most aromatic nitrogen heterocycles resulted in a significant reduction in both enzyme inhibition and antibacterial activity (Table 1 and Table 3). In contrast, introduction of either amino or nitro substituents at the ortho and para positions had only a minimal effect on activity ( Table 2).…”
mentioning
confidence: 99%